Antares Pharma (ATRS) Misses Q3 EPS by 32c
Antares Pharma (NASDAQ: ATRS) reported Q3 EPS of ($0.32). Revenue for the quarter came in at $3.5 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
Antares Pharma (NASDAQ: ATRS) reported Q3 EPS of ($0.32). Revenue for the quarter came in at $3.5 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.